超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

美國(guó)ImmunoChemistry  
  ImmunoChemistry公司成立于1994年，作為研發(fā)、銷(xiāo)售于一體的免疫化學(xué)生物技術(shù)公司，提供各種獨(dú)特的細(xì)胞蛋白酶、細(xì)胞凋亡與細(xì)胞毒性檢測(cè)試劑盒。
ImmunoChemistry公司產(chǎn)品FLICA?、Magic Red?、MitoPT?、FLISP?、Cholinesterase和膽堿酯酶等全細(xì)胞蛋白酶檢測(cè)試劑盒，不采用酶聯(lián)免疫方法也不使用抗體，通過(guò)使用熒光標(biāo)記的滲透細(xì)胞底物與由活性蛋白酶標(biāo)記多肽序列的抑制劑，對(duì)細(xì)胞內(nèi)活性凋亡蛋白酶、組織蛋白酶、絲氨酸蛋白酶、膽堿酯酶、功能性線粒體進(jìn)行測(cè)定，便可定量分析細(xì)胞凋亡與細(xì)胞毒性。




ImmunoChemistry Technologies, LLC (ICT) is a biotechnology company based in Bloomington, Minnesota, USA. ICT is a limited liability company (LLC) and is owned and managed by four partners:

Gary L. Johnson, President
Dr. Brian W. Lee, Vice President of R&D
Sally Hed, Vice President of Marketing & Operations
Carol Lee, Board Member
 

History

ICT was founded in 1994 and financed by the owners. Since then, ICT has grown into a profitable business with many employees. ICT started as contract laboratory focusing on custom immunoassay development services and selling ELISA products. In 1999, ICT expanded its product lines by developing detection reagents for cell death and related areas of basic research. Today we have over 30 distributors selling our products worldwide. From 2008-2010, ICT was awarded almost $2 million from the NIH for four grant projects to develop in vivo tracer biomarker reagents. ICT has also established several key collaborations with academic and corporate partners to further develop its in-house technology for in vivo detection. In 2010, ICT reinvested over half of its income into R&D.

Products, Services, & Research

ICT is one of the world's leading suppliers of unique in vivo and in vitro detection tools critical for discovering promising investigational medicines. ICT's fluorescent detection probes are used to assess apoptosis and cell death in cultured cells and living animals. ICT's specialty in vitro probes detect active caspases, cathepsins, serine proteases, cholinesterase enzymes, and assess mitochondrial health. ICT’s proprietary FLIVO probes are used in vivo to assess apoptosis in living animal research models.?FLIVO may be used to assess the efficacy of chemotherapy, to quantify neurodegeneration, and as an early detector of eye disease, among other applications. It may eventually be used to better manage disease and personalize treatment.
FLIVO won LifeScience Alley's New Technology Showcase Award in Dec. 2008.

ICT's contract laboratory specializes in custom ELISA development, manufacturing, and testing services. As an out-growth of these services, ICT offers a specialty line of ELISA buffers and stabilizers for assay development and manufacturing.